MYOVIEW
Details
- Status
- Prescription
- First Approved
- 1996-02-09
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
MYOVIEW Approval History
What MYOVIEW Treats
4 indicationsMYOVIEW is approved for 4 conditions since its original approval in 1996. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Myocardial Ischemia
- Myocardial Infarction
- Coronary Artery Disease
- Heart Disease
Drugs Similar to MYOVIEW
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MYOVIEW FDA Label Details
ProIndications & Usage
FDA Label (PDF)MYOVIEW is a kit for the preparation of technetium Tc99m tetrofosmin for injection. Technetium Tc99m tetrofosmin injection is a radioactive diagnostic agent indicated for the following: Myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease Assessment of left ventricular function (left ventricular ejection fraction and wall motion) in patients with known or suspected heart disease 1.1 Myocardial Perfusion Imaging Myocardi...
MYOVIEW Patents & Exclusivity
Patents (1 active)
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.